Trial Profile
An open, randomised parallel study investigating efficacy and safety of the human hepatitis B immunoglobulin BT088 after subcutaneous or intramuscular application for perinatal prophylaxis in infants born to HbsAg positive women
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Mar 2013
Price :
$35
*
At a glance
- Drugs Hepatitis B immune globulin (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Biotest AG
- 31 May 2011 New trial record